8 unknown. 8 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 8 | Unknown 8 |
Follow Multiple Myeloma: new trials by email Literature Review of Multiple Myeloma trials Research Report on Multiple Myeloma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized, Comparative, Double-blind Trial of Pentaisomaltose and Dimethyl Sulphoxide for Cryoprotection of Hematopoietic Stem Cells in Subjects With Multiple Myeloma or Malignant Lymphoma With a Need for Autologous Transplantation Pentaisomaltose - Malignant Lymphoma, Multiple Myeloma | Phase 4 | Unknown | Pharmacosmos A/S | 150 | 2024-04-30 | 2024-04-03 |
| Safety and ASCT-related Symptom Burden Optimization of Tocilizumab in ASCT Following HD Melphalan Conditioning for Multiple Myeloma Patients Tocilizumab - Multiple Myeloma | Phase 4 | Unknown | The First Affiliated Hospital of Soochow University | 48 | 2023-04-17 | 2023-06-02 |
| Study of Pomalidomide, Oral Dexamethasone and Ixazomib in Patients With Relapsed MM Who Have Received Lenalidomide Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone - Multiple Myeloma | Phase 4 | Unknown | Peking Union Medical College Hospital | 60 | 2021-07-26 | 2021-08-19 |
| RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma RDD, VDD - Hematologic Neoplasms, Multiple Myeloma | Phase 4 | Unknown | Shandong Provincial Hospital | 120 | 2019-03-30 | 2019-11-29 |
| PDD vs PAD to Treat Initially Diagnosed MM PDD regimen: doxorubicin hydrochloride iposome, bortizomib and dexamethasone, PAD regimen: bortizomib, dexamethasone and doxorubicin - Multiple Myeloma | Phase 4 | Unknown | The First Affiliated Hospital of Soochow University | 64 | 2015-10-01 | 2020-02-05 |
| A Study of PAD Versus Velcade, Cyclophosphamide and Dexamethasone (VCD) Treatment in Subjects With Multiple Myeloma PAD, VCD, ASCT - Multiple Myeloma | Phase 4 | Unknown | Peking University People's Hospital | 50 | 2013-05-01 | 2013-06-06 |
| Modified Bortezomib-based Combination Therapy for Multiple Myeloma Bortezomib, Dexamethasone, Doxorubicin - Multiple Myeloma | Phase 4 | Unknown | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 80 | 2010-07-01 | 2018-05-04 |
| Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma Bortezomib,Pirarubicin,Dexamethasone, Thalidomide,Pirarubicin,Dexamethasone - Multiple Myeloma | Phase 4 | Unknown | Second Military Medical University | 100 | 2010-06-01 | 2010-11-30 |
Hematologic Neoplasms (1) · Lymphoma (1)
Blood Protein Disorders (8) · Cardiovascular Diseases (8) · Hematologic Diseases (8) · Hemic and Lymphatic Diseases (8) · Hemorrhagic Disorders (8) · Hemostatic Disorders (8) · Immune System Diseases (8) · Immunoproliferative Disorders (8) · Lymphoproliferative Disorders (8) · Neoplasms (8) · Neoplasms by Histologic Type (8) · Neoplasms, Plasma Cell (8) · Paraproteinemias (8) · Vascular Diseases (8) · Lymphatic Diseases (1)
Bortezomib (2) · Dexamethasone (2) · Doxorubicin (2) · Thalidomide (2) · Cyclophosphamide (1) · Neoadjuvant Therapy (1) · tocilizumab (1)
The First Affiliated Hospital of Soochow University (2) · Peking Union Medical College Hospital (1) · Peking University People's Hospital (1) · Pharmacosmos A/S (1) · Second Military Medical University (1) · Shandong Provincial Hospital (1) · Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (1)
China (7)
Guohua Liu, MD (1) · Jian Hou, PhD (1) · Jin Lu, PhD (1) · Junling Zhuang, MD (1) · Xin Wang, PhD, MD (1)